Long Ideas - Cadence Pharmaceuticals (NASDAQ:CADX) announced that it will terminate its option to acquire privately-held Incline Therapeutics in order for The Medicines Company (NASDAQ:MDCO) to buy Incline … Continue Reading
Read nowLong Ideas - Sucampo Pharmaceuticals (NASDAQ:SCMP) has announced that its commercialization partner for Japan, Abbot Labs (NYSE:ABT), recorded the first sale in the country of Sucampo’s prescription treatment … Continue Reading
Read nowLong Ideas - Biogen Idec (BIIB) and Isis Pharmaceuticals (ISIS) announced another partnership deal on Monday, the third in the last year, for the discovery and development of … Continue Reading
Read nowLong Ideas - Halozyme Therapeutics (NASDAQ:HALO) announced on Saturday that its partner Roche (OTC: RHHBY) submitted its European application to market subcutaneous (SC) MabThera, also known as Rituxan. … Continue Reading
Read nowQuick Picks - Shares of Sequenom (SQNM) climbed 6% on Friday morning as investors took confidence in the announcement of a new patent issuance covering Sequenom’s methods for … Continue Reading
Read nowLong Ideas - The price action in shares of Questcor Pharmaceuticals (QCOR) Thursday was telling, with a quick reaction to a negative article published on the company, followed … Continue Reading
Read nowMost Popular - Coincident with securing $100M in non-equity financing, Amarin Corp. (AMRN) announced after the close on Thursday that it will begin hiring a sales force to … Continue Reading
Read now